Get the Stockscreener App
4.055
0.86%
-0.035
After Hours:
4.06
0.005
+0.12%
Alvotech stock is traded at $4.055, with a volume of 607.25K.
It is down -0.86% in the last 24 hours and up +22.88% over the past month.
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
See More
Previous Close:
$4.09
Open:
$4.15
24h Volume:
607.25K
Relative Volume:
0.73
Market Cap:
$1.37B
Revenue:
$563.46M
Net Income/Loss:
$27.92M
P/E Ratio:
42.06
EPS:
0.0964
Net Cash Flow:
$-146.33M
1W Performance:
+6.43%
1M Performance:
+22.88%
6M Performance:
-12.61%
1Y Performance:
-52.15%
1-Day Range:
$3.985
$4.185
1-Week Range:
$3.685
$4.185
52-Week Range:
$2.94
$9.25
Alvotech Stock (ALVO) Company Profile
Compare ALVO vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
4.055 | 1.36B | 563.46M | 27.92M | -146.33M | 0.0964 |
TAK
Takeda Pharmaceutical Co Adr
|
17.63 | 55.60B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.77 | 42.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.70 | 43.16B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.79 | 30.39B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
499.73 | 21.95B | 3.17B | 1.29B | 1.01B | 27.09 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Underweight |
| Nov-04-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-14-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-14-25 | Initiated | UBS | Buy |
| Jan-29-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-20-23 | Upgrade | Citigroup | Sell → Neutral |
| Sep-21-23 | Initiated | Barclays | Equal Weight |
| Sep-07-22 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-06-22 | Downgrade | Citigroup | Buy → Sell |
| Jul-26-22 | Initiated | Citigroup | Buy |
View All
Alvotech Stock (ALVO) Latest News
Long term debt to total equity ratio of Alvotech Swedish Depository Receipt Repr 1 Sh – TURQUOISE:ALVOS - TradingView
Alvotech (Z45) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (Z45) Q3 2023 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (Z45) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (Z45) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (Z45) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Evercore ISI initiates Alvotech stock with outperform rating - Investing.com
ALVO|Alvotech SA|Price:4.100|Chg%:+0.010 - TradingKey
Alvotech (Z45) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Earnings Preview: Alvotech to Report Financial Results Post-market on August 19 - Moomoo
Alvotech (ALVO) to Announce Earnings on Wednesday - marketbeat.com
Did FDA’s Positive Reykjavik Plant Outcome Just Shift Alvotech’s (ALVO) Biosimilar Expansion Narrative? - simplywall.st
Alvotech to Report Financial Results for H1 2026 - The Manila Times
Alvotech to Report First-Half 2026 Financial Results on August 19 and Host Webcast on August 20 - Quiver Quantitative
Alvotech Schedules Live Q&A After Its H1 2026 Results Release - Stock Titan
ALVO Stock Price Prediction 2025-2026 | Alvotech Forecast - 24/7 Wall St.
Why is Alvotech stock rallying today? By Investing.com - Investing.com Nigeria
Alvotech (ALVO) Could Be 72% Undervalued Following FDA Inspection Closure - simplywall.st
Alvotech (ALVO) Is Up 34.6% After FDA Clears Reykjavik Plant And BLAs AdvanceHas The Bull Case Changed? - webull.com
Alvotech (NASDAQ:ALVO) Shares Down 6.7%Time to Sell? - marketbeat.com
Alvotech (NASDAQ:ALVO) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Alvotech $ALVO Shares Sold by Oaktree Capital Management LP - marketbeat.com
Alvotech Shares Rise After Wrapping FDA Facility Inspection - Moomoo
Alvotech announces successful closure of FDA inspection of manufacturing facility - globenewswire.com
FDA closes Alvotech (NASDAQ: ALVO) Iceland plant inspection with VAI status - Stock Titan
Alvotech SA (ALVO) Cash Flow - TradingKey
Alvotech SA (ALVO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alvotech Revenue Breakdown – NASDAQ:ALVOW - TradingView
Alvotech (ALVO) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (ALVO) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (ALVO) Q3 2023 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (ALVO) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (ALVO) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (ALVO) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Alvotech Revenue Breakdown – NASDAQ:ALVO - TradingView
Alvotech SA (ALVO) Income Statement - TradingKey
TradingKey - TradingKey
ALVO Stock Price, Quote & Chart - ChartMill
Alvotech (ALVO) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Alvotech (NASDAQ:ALVO) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Alvotech (NASDAQ:ALVO) Slides as Market Concerns Deepen - Kalkine Media
Alvotech (NASDAQ:ALVO) Stock Price Down 7.8%Here's What Happened - MarketBeat
Inspection Findings Highlight Hurdles Facing Alvotech’s Launch Plans - insights.citeline.com
Alvotech files automatic mixed securities shelf - MSN
Novo, Alvotech face continued scrutiny at plants tied to recent FDA rejections - Fierce Pharma
Alvotech (ALVO) Could Be 76% Below Fair Value On New $75 Million Debt Facility - simplywall.st
Alvotech (NASDAQ:ALVO) Shares Down 5.5%Here's What Happened - MarketBeat
Alvotech (ALVO) Barclays 27th Annual Global Healthcare Conference 2025 Summary - Quartr
ETFs Investing in Alvotech Stocks - TradingView
Enterprise value to EBITDA forward of Alvotech – NASDAQ:ALVO - TradingView
Alvotech (ALVO) Q3 2025 earnings summary - Quartr
Alvotech Stock (ALVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
5.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):